{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T06:05:44Z","timestamp":1768457144852,"version":"3.49.0"},"reference-count":80,"publisher":"Walter de Gruyter GmbH","issue":"6","license":[{"start":{"date-parts":[[2014,6,11]],"date-time":"2014-06-11T00:00:00Z","timestamp":1402444800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Immunol. Ther. Exp."],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s00005-014-0294-x","type":"journal-article","created":{"date-parts":[[2014,6,10]],"date-time":"2014-06-10T19:54:14Z","timestamp":1402430054000},"page":"475-482","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Role of Osteopontin in Systemic Lupus Erythematosus"],"prefix":"10.2478","volume":"62","author":[{"given":"Beata","family":"Kaleta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2014,6,11]]},"reference":[{"key":"294_CR1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/1876894600901010059","volume":"1","author":"MF Afify","year":"2009","unstructured":"Afify MF, Mohamed GB, El-Maboud MA et al (2009) Plasma concentration of osteopontin (OPN) in children with systemic lupus erythematosus: relationship with disease activity. Open Autoimmun J 1:59\u201363","journal-title":"Open Autoimmun J"},{"key":"294_CR2","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/jcb.20379","volume":"94","author":"R Al-Shami","year":"2005","unstructured":"Al-Shami R, S\u00f8rensen ES, Ek-Rylander B et al (2005) Phosphorylated osteopontin promotes migration of human choriocarcinoma cells via a p70 S6 kinase-dependent pathway. J Cell Biochem 94:1218\u20131233","journal-title":"J Cell Biochem"},{"key":"294_CR3","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1126\/science.287.5454.860","volume":"287","author":"S Ashkar","year":"2000","unstructured":"Ashkar S, Weber GF, Panoutsakopoulou V et al (2000) Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 287:860\u2013864","journal-title":"Science"},{"key":"294_CR4","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1191\/096120300674499064","volume":"9","author":"AA Bengtsson","year":"2000","unstructured":"Bengtsson AA, Sturfelt G, Truedsson L et al (2000) Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies. Lupus 9:664\u2013671","journal-title":"Lupus"},{"key":"294_CR5","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1191\/096120301678416042","volume":"10","author":"S Blomberg","year":"2001","unstructured":"Blomberg S, Eloranta ML, Cederblad B et al (2001) Presence of cutaneous interferon-alpha producing cells in patients with systemic lupus erythematosus. Lupus 10:484\u2013490","journal-title":"Lupus"},{"key":"294_CR6","doi-asserted-by":"crossref","first-page":"288","DOI":"10.2478\/s13380-012-0028-7","volume":"3","author":"A Brown","year":"2012","unstructured":"Brown A (2012) Osteopontin: a key link between immunity, inflammation and the central nervous system. Transl Neurosci 3:288\u2013293","journal-title":"Transl Neurosci"},{"key":"294_CR7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1749-6632.1995.tb44626.x","volume":"760","author":"H Cantor","year":"1995","unstructured":"Cantor H (1995) The role of Eta-1\/osteopontin in the pathogenesis of immunological disorders. Ann N Y Acad Sci 760:143\u2013150","journal-title":"Ann N Y Acad Sci"},{"key":"294_CR8","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.3748\/wjg.v18.i30.3923","volume":"18","author":"DX Cao","year":"2012","unstructured":"Cao DX, Li ZJ, Jiang XO et al (2012) Osteopontin as potential biomarker and therapeutic target in gastric and liver cancers. World J Gastroenterol 18:3923\u20133930","journal-title":"World J Gastroenterol"},{"key":"294_CR9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3233\/JAD-2011-102151","volume":"25","author":"M Carecchio","year":"2011","unstructured":"Carecchio M, Comi C (2011) The role of osteopontin in neurodegenerative diseases. J Alzheimers Dis 25:179\u2013185","journal-title":"J Alzheimers Dis"},{"key":"294_CR10","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.oraloncology.2010.01.018","volume":"46","author":"YW Chiu","year":"2010","unstructured":"Chiu YW, Tu HF, Wang IK et al (2010) The implication of osteopontin (OPN) expression and genetic polymorphisms of OPN promotor in oral carcinogenesis. Oral Oncol 46:302\u2013306","journal-title":"Oral Oncol"},{"key":"294_CR11","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s11883-009-0032-8","volume":"11","author":"HJ Cho","year":"2009","unstructured":"Cho HJ, Cho HJ, Kim HS (2009) Osteopontin: a multifunctional protein at the crossroads of inflammation, atherosclerosis, and vascular calcification. Curr Atheroscler Rep 11:206\u2013213","journal-title":"Curr Atheroscler Rep"},{"key":"294_CR12","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/art.20808","volume":"52","author":"S D\u2019Alfonso","year":"2005","unstructured":"D\u2019Alfonso S, Barizzone N, Giordano M et al (2005) Two single-nucleotide polymorphisms in the 50 and 30 ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus. Arthritis Rheum 52:539\u2013547","journal-title":"Arthritis Rheum"},{"key":"294_CR13","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1091\/mbc.9.6.1425","volume":"9","author":"S Denda","year":"1998","unstructured":"Denda S, Reichardt L, M\u00fcller U (1998) Identification of osteopontin as a novel ligand for the integrin alpha 8 beta 1 and potential role for this integrin-ligand interaction in kidney morphogenesis. Mol Biol Cell 9:1425\u20131435","journal-title":"Mol Biol Cell"},{"key":"294_CR14","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1096\/fasebj.7.15.8262332","volume":"7","author":"DT Denhardt","year":"1993","unstructured":"Denhardt DT, Guo X (1993) Osteopontin: a protein with the diverse functions. FASEB J 7:1475\u20131482","journal-title":"FASEB J"},{"key":"294_CR15","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/(SICI)1097-4644(1998)72:30\/31+<92::AID-JCB13>3.0.CO;2-A","volume":"30","author":"DT Denhardt","year":"1998","unstructured":"Denhardt DT, Noda M (1998) Osteopontin expression and function: role in bone remodeling. J Cell Biochem Suppl 30:92\u2013102","journal-title":"J Cell Biochem Suppl"},{"key":"294_CR16","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1006\/bbrc.2000.4146","volume":"280","author":"LW Fisher","year":"2001","unstructured":"Fisher LW, Torchia DA, Fohr B et al (2001) Flexible structures of SIBLING proteins, bone sialoprotein, and osteopontin. Biochem Biophys Res Commun 280:460\u2013465","journal-title":"Biochem Biophys Res Commun"},{"key":"294_CR17","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/humu.9025","volume":"19","author":"AC Forton","year":"2002","unstructured":"Forton AC, Petri MA, Goldman D et al (2002) An osteopontin (SPP1) polymorphism is associated with systemic lupus erythematosus. Hum Mutat 19:459","journal-title":"Hum Mutat"},{"key":"294_CR18","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1586\/eci.10.82","volume":"7","author":"DF Frenzel","year":"2011","unstructured":"Frenzel DF, Weiss JM (2011) Osteopontin and allergic disease: pathophysiology and implications for diagnostics and therapy. Expert Rev Clin Immunol 7:93\u2013109","journal-title":"Expert Rev Clin Immunol"},{"key":"294_CR19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00223-004-1288-1","volume":"77","author":"A Gericke","year":"2005","unstructured":"Gericke A, Qin C, Spevak L et al (2005) Importance of phosphorylation for osteopontin regulation of biomineralization. Calcif Tissue Int 77:45\u201354","journal-title":"Calcif Tissue Int"},{"key":"294_CR20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3727\/000000003108748991","volume":"11","author":"F Giacopelli","year":"2003","unstructured":"Giacopelli F, Rosatto N, Divizia MT et al (2003) The first intron of the human osteopontin gene contains a C\/EBP-beta-responsive enhancer. Gene Expr 11:95\u2013104","journal-title":"Gene Expr"},{"key":"294_CR21","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s12026-012-8345-z","volume":"55","author":"BM Giles","year":"2013","unstructured":"Giles BM, Boackle SA (2013) Linking complement and anti-dsDNA antibodies in the pathogenesis of systemic lupus erythematosus. Immunol Res 55:10\u201321","journal-title":"Immunol Res"},{"key":"294_CR22","doi-asserted-by":"crossref","first-page":"e29309","DOI":"10.1371\/journal.pone.0029309","volume":"6","author":"J Glas","year":"2011","unstructured":"Glas J, Seiderer J, Bayrle C et al (2011) The role of osteopontin (OPN\/SPP1) haplotypes in the susceptibility to Crohn\u2019s disease. PLoS One 6:e29309","journal-title":"PLoS One"},{"key":"294_CR23","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1172\/JCI200319190","volume":"112","author":"EM Gravallese","year":"2003","unstructured":"Gravallese EM (2003) Osteopontin: a bridge between bone and the immune system. J Clin Invest 112:147\u2013149 (erratum in: J Clin Invest 112:627)","journal-title":"J Clin Invest"},{"key":"294_CR24","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0014-5793(01)02690-4","volume":"503","author":"PM Green","year":"2001","unstructured":"Green PM, Ludbrook SB, Miller DD et al (2001) Structural elements of the osteopontin SVVYGLR motif important for the interaction with alpha (4) integrins. FEBS Lett 503:75\u201379","journal-title":"FEBS Lett"},{"key":"294_CR25","doi-asserted-by":"crossref","first-page":"e0001757","DOI":"10.1371\/journal.pone.0001757","volume":"3","author":"S Han","year":"2008","unstructured":"Han S, Guthridge JM, Harley IT et al (2008) Osteopontin and systemic lupus erythematosus association: a probable gene-gender interaction. PLoS One 3:e0001757","journal-title":"PLoS One"},{"key":"294_CR26","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF03256329","volume":"13","author":"VK Harris","year":"2009","unstructured":"Harris VK, Sadiq SA (2009) Disease biomarkers in multiple sclerosis: potential for use in therapeutic decision making. Mol Diagn Ther 13:225\u2013244","journal-title":"Mol Diagn Ther"},{"key":"294_CR27","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/j.1582-4934.2008.00428.x","volume":"13","author":"K Heilmann","year":"2009","unstructured":"Heilmann K, Hoffmann U, Witte E et al (2009) Osteopontin as two-sided mediator of intestinal inflammation. J Cell Mol Med 13:1162\u20131174","journal-title":"J Cell Mol Med"},{"key":"294_CR28","doi-asserted-by":"crossref","first-page":"26232","DOI":"10.1074\/jbc.270.44.26232","volume":"270","author":"DD Hu","year":"1995","unstructured":"Hu DD, Lin EC, Kovach NL et al (1995) A biochemical characterization of the binding of osteopontin to integrins alpha v beta 1 and alpha v beta 5. J Biol Chem 270:26232\u201326238","journal-title":"J Biol Chem"},{"key":"294_CR29","first-page":"1523","volume":"78","author":"J Iizuka","year":"1998","unstructured":"Iizuka J, Katagiri Y, Tada N et al (1998) Introduction of an osteopontin gene confers the increase in B1 cell population and the production of anti-DNA autoantibodies. Lab Invest 78:1523\u20131533","journal-title":"Lab Invest"},{"key":"294_CR30","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.matbio.2008.10.002","volume":"28","author":"K Ito","year":"2009","unstructured":"Ito K, Kon S, Nakayama Y et al (2009) The differential amino acid requirement within osteopontin in alpha 4 and alpha 9 integrin-mediated cell binding and migration. Matrix Biol 28:11\u201319","journal-title":"Matrix Biol"},{"key":"294_CR31","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s100380170037","volume":"46","author":"H Iwasaki","year":"2001","unstructured":"Iwasaki H, Shinohara Y, Ezura Y et al (2001) Thirteen single-nucleotide polymorphisms in the human osteopontin gene identified by sequencing of the entire gene in Japanese individuals. J Hum Genet 46:544\u2013546","journal-title":"J Hum Genet"},{"key":"294_CR32","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1186\/ar4129","volume":"15","author":"Y Jiang","year":"2013","unstructured":"Jiang Y, Yao M, Liu Q et al (2013) OPN gene polymorphisms influence the risk of knee OA and OPN levels in synovial fluid in a Chinese population. Arthritis Res Ther 15:R3","journal-title":"Arthritis Res Ther"},{"key":"294_CR33","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.trsl.2009.08.012","volume":"155","author":"SN Kariuki","year":"2010","unstructured":"Kariuki SN, Niewold TB (2010) Genetic regulation of serum cytokines in systemic lupus erythematosus. Transl Res 155:109\u2013117","journal-title":"Transl Res"},{"key":"294_CR34","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/gene.2009.15","volume":"10","author":"SN Kariuki","year":"2009","unstructured":"Kariuki SN, Moore JG, Kirou KA et al (2009) Age- and gender-specific modulation of serum osteopontin and interferon-alpha by osteopontin genotype in systemic lupus erythematosus. Genes Immun 10:487\u2013494","journal-title":"Genes Immun"},{"key":"294_CR35","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1749-6632.1995.tb44660.x","volume":"760","author":"Y Katagiri","year":"1995","unstructured":"Katagiri Y, Mori K, Hara T et al (1995) Functional analysis of the osteopontin molecule. Ann N Y Acad Sci 760:371\u2013374","journal-title":"Ann N Y Acad Sci"},{"key":"294_CR36","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/jcb.21558","volume":"102","author":"CC Kazanecki","year":"2007","unstructured":"Kazanecki CC, Uzwiak DJ, Denhardt DT (2007) Control of osteopontin signaling and function by post-translational phosphorylation and protein folding. J Cell Biochem 102:912\u2013924","journal-title":"J Cell Biochem"},{"key":"294_CR37","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1365-2567.2007.02682.x","volume":"122","author":"A Koh","year":"2007","unstructured":"Koh A, da Silva AP, Bansal AK et al (2007) Role of osteopontin in neutrophil function. Immunology 122:466\u2013475","journal-title":"Immunology"},{"key":"294_CR38","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1111\/j.1365-2222.2011.03775.x","volume":"41","author":"S Konno","year":"2011","unstructured":"Konno S, Kurokawa M, Uede T et al (2011) Role of osteopontin, a multifunctional protein, in allergy and asthma. Clin Exp Allergy 41:1360\u20131366","journal-title":"Clin Exp Allergy"},{"key":"294_CR39","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1002\/1521-4141(200007)30:7<2038::AID-IMMU2038>3.0.CO;2-K","volume":"30","author":"D Kontoyiannis","year":"2000","unstructured":"Kontoyiannis D, Kollias G (2000) Accelerated autoimmunity and lupus nephritis in NZB mice with an engineered heterozygous deficiency in tumor necrosis factor. Eur J Immunol 30:2038\u20132047","journal-title":"Eur J Immunol"},{"key":"294_CR40","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0092-8674(00)81108-3","volume":"85","author":"BL Kotzin","year":"1996","unstructured":"Kotzin BL (1996) Systemic lupus erythematosus. Cell 85:303\u2013306","journal-title":"Cell"},{"key":"294_CR41","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.4049\/jimmunol.147.9.2902","volume":"147","author":"MA Lampe","year":"1991","unstructured":"Lampe MA, Patarca R, Iregui MV et al (1991) Polyclonal B cell activation by the Eta-1 cytokine and the development of systemic autoimmune disease. J Immunol 147:2902\u20132906","journal-title":"J Immunol"},{"key":"294_CR42","first-page":"84","volume":"3","author":"L Li","year":"1999","unstructured":"Li L, Yu XQ, Yin PD et al (1999) [OPN expression of peripheral blood mononuclear cells in systemic lupus erythematosus (SLE) and its clinical significance] in Chinese. Chin J Rheumatol 3:84\u201386","journal-title":"Chin J Rheumatol"},{"key":"294_CR43","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/icb.2011.108","volume":"90","author":"R Lindop","year":"2012","unstructured":"Lindop R, Arentz G, Thurgood LA et al (2012) Pathogenicity and proteomic signatures of autoantibodies to Ro and La. Immunol Cell Biol 90:304\u2013309","journal-title":"Immunol Cell Biol"},{"key":"294_CR44","first-page":"320","volume":"39","author":"B Lou","year":"2006","unstructured":"Lou B, Lv J, Zheng M (2006) The relationship between osteopontin plasma concentration and disease activity in systemic lupus erythematosus. Chin J Dermatol 39:320\u2013321","journal-title":"Chin J Dermatol"},{"key":"294_CR45","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1007\/s00467-011-2078-4","volume":"27","author":"SD Marks","year":"2012","unstructured":"Marks SD, Tullus K (2012) Autoantibodies in systemic lupus erythematosus. Pediatr Nephrol 27:1855\u20131868","journal-title":"Pediatr Nephrol"},{"key":"294_CR46","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1056\/NEJM199406303302608","volume":"330","author":"JA Mills","year":"1994","unstructured":"Mills JA (1994) Systemic lupus erythematosus. N Engl J Med 330:1871\u20131879","journal-title":"N Engl J Med"},{"key":"294_CR47","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/MCG.0b013e31802d6268","volume":"41","author":"R Mishima","year":"2007","unstructured":"Mishima R, Takeshima F, Sawai T et al (2007) High plasma osteopontin levels in patients with inflammatory bowel disease. J Clin Gastroenterol 41:167\u2013172","journal-title":"J Clin Gastroenterol"},{"key":"294_CR48","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1002\/eji.200425672","volume":"35","author":"T Miyazaki","year":"2005","unstructured":"Miyazaki T, Ono M, Qu WM et al (2005) Implication of allelic polymorphism of osteopontin in the development of lupus nephritis in MRL\/lpr mice. Eur J Immunol 35:1510\u20131520","journal-title":"Eur J Immunol"},{"key":"294_CR49","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.bbrc.2003.12.045","volume":"313","author":"S Mochida","year":"2004","unstructured":"Mochida S, Hashimoto M, Matsui A et al (2004) Genetic polymorphisms in promoter region of osteopontin gene may be a marker reflecting hepatitis activity in chronic hepatitis C patients. Biochem Biophys Res Commun 313:1079\u20131085","journal-title":"Biochem Biophys Res Commun"},{"key":"294_CR50","doi-asserted-by":"crossref","first-page":"7480","DOI":"10.4049\/jimmunol.181.11.7480","volume":"181","author":"G Murugaiyan","year":"2008","unstructured":"Murugaiyan G, Mittal A, Weiner HL (2008) Increased osteopontin expression in dendritic cells amplifies IL-17 production by CD4+ T cells in experimental autoimmune encephalomyelitis and in multiple sclerosis. J Immunol 181:7480\u20137488","journal-title":"J Immunol"},{"key":"294_CR51","doi-asserted-by":"crossref","first-page":"8819","DOI":"10.1073\/pnas.83.23.8819","volume":"83","author":"A Oldberg","year":"1986","unstructured":"Oldberg A, Franzen A, Heinegard D (1986) Cloning and sequence analysis of rat bone sialoprotein (osteopontin), cDNA reveals an Arg-Gly-Asp cell binding sequence. Proc Natl Acad Sci USA 83:8819\u20138823","journal-title":"Proc Natl Acad Sci USA"},{"key":"294_CR52","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1046\/j.1523-1755.1999.00580.x","volume":"56","author":"V Ophascharoensuk","year":"1999","unstructured":"Ophascharoensuk V, Giachelli CM, Gordon K et al (1999) Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis. Kidney Int 56:571\u2013580","journal-title":"Kidney Int"},{"key":"294_CR53","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1084\/jem.170.1.145","volume":"170","author":"R Patarca","year":"1989","unstructured":"Patarca R, Freeman GJ, Singh RP et al (1989) Structural and functional studies of the early T lymphocyte activation 1 (Eta-1) gene. Definition of a novel T cell-dependent response associated with genetic resistance to bacterial infection. J Exp Med 170:145\u2013161","journal-title":"J Exp Med"},{"key":"294_CR54","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/toxsci\/kfm246","volume":"103","author":"SK Ramaiah","year":"2008","unstructured":"Ramaiah SK, Rittling S (2008) Pathophysiological role of osteopontin in hepatic inflammation, toxicity, and cancer. Toxicol Sci 103:4\u201313","journal-title":"Toxicol Sci"},{"key":"294_CR55","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.tcb.2005.12.005","volume":"16","author":"H Rangaswami","year":"2006","unstructured":"Rangaswami H, Bulbule A, Kundu GC (2006) Osteopontin: role in cell signaling and cancer progression. Trends Cell Biol 16:79\u201387","journal-title":"Trends Cell Biol"},{"key":"294_CR56","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S8756-3282(01)00637-8","volume":"30","author":"S Razzouk","year":"2002","unstructured":"Razzouk S, Brunn JC, Qin C et al (2002) Osteopontin posttranslational modifications, possibly phosphorylation, are required for in vitro bone resorption but not osteoclast adhesion. Bone 30:40\u201347","journal-title":"Bone"},{"key":"294_CR57","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.autrev.2011.10.021","volume":"11","author":"OP Rekvig","year":"2012","unstructured":"Rekvig OP, Putterman C, Casu C et al (2012) Autoantibodies in lupus: culprits or passive bystanders? Autoimmun Rev 11:596\u2013603","journal-title":"Autoimmun Rev"},{"key":"294_CR58","doi-asserted-by":"crossref","first-page":"R18","DOI":"10.1186\/ar4150","volume":"15","author":"OJ Rullo","year":"2013","unstructured":"Rullo OJ, Woo JM, Parsa MF et al (2013) Plasma levels of osteopontin identify patients at risk for organ damage in systemic lupus erythematosus. Arthritis Res Ther 15:R18","journal-title":"Arthritis Res Ther"},{"key":"294_CR59","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1161\/ATVBAHA.107.144824","volume":"27","author":"M Scatena","year":"2007","unstructured":"Scatena M, Liaw L, Giachelli CM (2007) Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol 27:2302\u20132309","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"294_CR60","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/ni1327","volume":"7","author":"ML Shinohara","year":"2006","unstructured":"Shinohara ML, Lu L, Bu J et al (2006) Osteopontin expression is essential for interferon-alpha production by plasmacytoid dendritic cells. Nat Immunol 7:498\u2013506","journal-title":"Nat Immunol"},{"key":"294_CR61","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.immuni.2008.05.008","volume":"29","author":"ML Shinohara","year":"2008","unstructured":"Shinohara ML, Kim JH, Garcia VA et al (2008) Engagement of the type I interferon receptor on dendritic cells inhibits T helper 17 cell development: role of intracellular osteopontin. Immunity 29:68\u201378","journal-title":"Immunity"},{"key":"294_CR62","doi-asserted-by":"crossref","first-page":"214","DOI":"10.2741\/2059","volume":"12","author":"M Singh","year":"2007","unstructured":"Singh M, Ananthula S, Milhorn DM et al (2007) Osteopontin: a novel inflammatory mediator of cardiovascular disease. Front Biosci 12:214\u2013221","journal-title":"Front Biosci"},{"key":"294_CR63","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/10454411000110030101","volume":"11","author":"J Sodek","year":"2000","unstructured":"Sodek J, Ganss B, McKee MD (2000) Osteopontin. Crit Rev Oral Biol Med 11:279\u2013303","journal-title":"Crit Rev Oral Biol Med"},{"key":"294_CR64","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1172\/JCI30065","volume":"118","author":"DL Thibault","year":"2008","unstructured":"Thibault DL, Chu AD, Graham KL et al (2008) IRF9 and STAT1 are required for IgG autoantibody production and B cell expression of TLR7 in mice. J Clin Invest 118:1417\u20131426","journal-title":"J Clin Invest"},{"key":"294_CR65","doi-asserted-by":"crossref","first-page":"802581","DOI":"10.1155\/2011\/802581","volume":"2011","author":"T Trivedi","year":"2011","unstructured":"Trivedi T, Franek BS, Green SL et al (2011) Osteopontin alleles are associated with clinical characteristics in systemic lupus erythematosus. J Biomed Biotechnol 2011:802581","journal-title":"J Biomed Biotechnol"},{"key":"294_CR66","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1440-1827.2011.02649.x","volume":"61","author":"T Uede","year":"2011","unstructured":"Uede T (2011) Osteopontin, intrinsic tissue regulator of intractable inflammatory diseases. Pathol Int 61:265\u2013280","journal-title":"Pathol Int"},{"key":"294_CR67","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/hep.24701","volume":"55","author":"R Urtasun","year":"2012","unstructured":"Urtasun R, Lopategi A, George J et al (2012) Osteopontin, an oxidant stress sensitive cytokine, up-regulates collagen-I via integrin \u03b1(V)\u03b2(3) engagement and PI3\u00a0K\/pAkt\/NF\u03baB signaling. Hepatology 55:594\u2013608","journal-title":"Hepatology"},{"key":"294_CR68","first-page":"109","volume":"17","author":"E Voronov","year":"2006","unstructured":"Voronov E, Dayan M, Zinger H et al (2006) IL-1 beta-deficient mice are resistant to induction of experimental SLE. Eur Cytokine Netw 17:109\u2013116","journal-title":"Eur Cytokine Netw"},{"key":"294_CR69","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cytogfr.2008.08.001","volume":"19","author":"KX Wang","year":"2008","unstructured":"Wang KX, Denhardt DT (2008) Osteopontin: role in immune regulation and stress response. Cytokine Growth Factor Rev 19:333\u2013345","journal-title":"Cytokine Growth Factor Rev"},{"key":"294_CR70","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1046\/j.1365-2249.2001.01702.x","volume":"126","author":"GF Weber","year":"2001","unstructured":"Weber GF, Cantor H (2001) Differential roles of osteopontin\/Eta-1 in early and late lpr disease. Clin Exp Immunol 126:578\u2013583","journal-title":"Clin Exp Immunol"},{"key":"294_CR71","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1126\/science.271.5248.509","volume":"271","author":"GF Weber","year":"1996","unstructured":"Weber GF, Ashkar S, Glimcher MJ et al (1996) Receptor\u2013ligand interaction between CD44 and osteopontin (Eta-1). Science 271:509\u2013512","journal-title":"Science"},{"key":"294_CR72","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1093\/rheumatology\/keh558","volume":"44","author":"CK Wong","year":"2005","unstructured":"Wong CK, Lit LC, Tam LS et al (2005) Elevation of plasma osteopontin concentration is correlated with disease activity in patients with systemic lupus erythematosus. Rheumatology 44:602\u2013606","journal-title":"Rheumatology"},{"key":"294_CR73","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3109\/08916939808996282","volume":"28","author":"RP W\u00fcthrich","year":"1998","unstructured":"W\u00fcthrich RP, Fan X, Ritthaler T et al (1998) Enhanced osteopontin expression and macrophage infiltration in MRL-Fas(lpr) mice with lupus nephritis. Autoimmunity 28:139\u2013150","journal-title":"Autoimmunity"},{"key":"294_CR74","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1097\/00029330-200712010-00011","volume":"120","author":"AP Xu","year":"2007","unstructured":"Xu AP, Bai J, L\u00fc J et al (2007a) Osteopontin gene polymorphism in association with systemic lupus erythematosus in Chinese patients. Chin Med J 120:2124\u20132128","journal-title":"Chin Med J"},{"key":"294_CR75","first-page":"1348","volume":"27","author":"AP Xu","year":"2007","unstructured":"Xu AP, Liang YY, L\u00fc J et al (2007b) Association of osteopontin gene polymorphism with lupus nephritis in Chinese Han population. Nan Fang Yi Ke Da Xue Xue Bao 27:1348\u20131351 (in Chinese)","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"294_CR76","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/nep.12047","volume":"18","author":"DY Yap","year":"2013","unstructured":"Yap DY, Lai KN (2013) The role of cytokines in the pathogenesis of systemic lupus erythematosus\u2014from bench to bedside. Nephrology 18:243\u2013255","journal-title":"Nephrology"},{"key":"294_CR77","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-2036.2012.05196.x","volume":"36","author":"Y Yilmaz","year":"2012","unstructured":"Yilmaz Y (2012) Review article: non-alcoholic fatty liver disease and osteoporosis-clinical and molecular crosstalk. Aliment Pharmacol Ther 36:345\u2013352","journal-title":"Aliment Pharmacol Ther"},{"key":"294_CR78","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.matbio.2005.05.005","volume":"24","author":"Y Yokosaki","year":"2005","unstructured":"Yokosaki Y, Tanaka K, Higashikawa F et al (2005) Distinct structural requirements for binding of the integrins alphavbeta6, alphavbeta3, alphavbeta5, alpha5beta1 and alpha9beta1 to osteopontin. Matrix Biol 24:418\u2013427","journal-title":"Matrix Biol"},{"key":"294_CR79","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/ki.1995.14","volume":"47","author":"H Yokoyama","year":"1995","unstructured":"Yokoyama H, Kreft B, Kelley VR (1995) Biphasic increase in circulating and renal TNF-alpha in MRL-lpr mice with differing regulatory mechanisms. Kidney Int 47:122\u2013130","journal-title":"Kidney Int"},{"key":"294_CR80","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1385\/CRIAI:25:1:29","volume":"25","author":"G Zandman-Goddard","year":"2003","unstructured":"Zandman-Goddard G, Shoenfeld Y (2003) SLE and infections. Clin Rev Allergy Immunol 25:29\u201340","journal-title":"Clin Rev Allergy Immunol"}],"container-title":["Archivum Immunologiae et Therapiae Experimentalis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00005-014-0294-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-014-0294-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-014-0294-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T20:48:17Z","timestamp":1704228497000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00005-014-0294-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,11]]},"references-count":80,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["294"],"URL":"https:\/\/doi.org\/10.1007\/s00005-014-0294-x","relation":{},"ISSN":["0004-069X","1661-4917"],"issn-type":[{"value":"0004-069X","type":"print"},{"value":"1661-4917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,11]]}}}